 | • レポートコード：D0804-14753 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、禁煙製品の世界市場を広く調査・分析し、今後の市場展望をまとめております。禁煙製品の種類別市場規模（ニコチン補充療法、薬物療法、電子タバコ）、用途別市場規模（18〜24歳の喫煙者、25〜44歳の喫煙者、45〜64歳の喫煙者、65歳以上の喫煙者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Imperial Tobacco、GSK、Cipla、Revolymer plc、Novartis International、NJOY、McNeil AB、Takeda pharmaceutical、Elder Pharma、VMR products、Lorillard、VaporCorp ・地域別グローバル市場分析 2015年-2020年 ・禁煙製品の北米市場（アメリカ、カナダ、メキシコ） ・禁煙製品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・禁煙製品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・禁煙製品の南米市場（ブラジル、アルゼンチン） ・禁煙製品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ニコチン補充療法、薬物療法、電子タバコ ・用途別分析：18〜24歳の喫煙者、25〜44歳の喫煙者、45〜64歳の喫煙者、65歳以上の喫煙者 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anti-Smoking Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-Smoking Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-Smoking Products market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-Smoking Products market has been segmented into:
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
By Application, Anti-Smoking Products has been segmented into:
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Smoking Products market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Smoking Products markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Smoking Products market.
The report offers in-depth assessment of the growth and other aspects of the Anti-Smoking Products market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-Smoking Products Market Share Analysis
Anti-Smoking Products competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Smoking Products sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Smoking Products sales, revenue and market share for each player covered in this report.
The major players covered in Anti-Smoking Products are:
Pfizer
Imperial Tobacco
GSK
Cipla
Revolymer plc
Novartis International
NJOY
McNeil AB
Takeda pharmaceutical
Elder Pharma
VMR products
Lorillard
VaporCorp
Table of Contents
1 Anti-Smoking Products Market Overview
1.1 Product Overview and Scope of Anti-Smoking Products
1.2 Classification of Anti-Smoking Products by Type
1.2.1 Global Anti-Smoking Products Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anti-Smoking Products Revenue Market Share by Type in 2019
1.2.3 Nicotine Replacement Therapy
1.2.4 Drug therapy
1.2.5 E-cigarettes
1.3 Global Anti-Smoking Products Market by Application
1.3.1 Overview: Global Anti-Smoking Products Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Smokers aged 18–24
1.3.3 Smokers aged 25–44
1.3.4 Smokers aged 45–64
1.3.5 Smokers aged 65 years or older
1.4 Global Anti-Smoking Products Market by Regions
1.4.1 Global Anti-Smoking Products Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anti-Smoking Products (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anti-Smoking Products Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-Smoking Products Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Smoking Products Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anti-Smoking Products Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Smoking Products Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.2 Imperial Tobacco
2.2.1 Imperial Tobacco Details
2.2.2 Imperial Tobacco Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Imperial Tobacco SWOT Analysis
2.2.4 Imperial Tobacco Product and Services
2.2.5 Imperial Tobacco Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cipla SWOT Analysis
2.4.4 Cipla Product and Services
2.4.5 Cipla Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.5 Revolymer plc
2.5.1 Revolymer plc Details
2.5.2 Revolymer plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Revolymer plc SWOT Analysis
2.5.4 Revolymer plc Product and Services
2.5.5 Revolymer plc Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International
2.6.1 Novartis International Details
2.6.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International SWOT Analysis
2.6.4 Novartis International Product and Services
2.6.5 Novartis International Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.7 NJOY
2.7.1 NJOY Details
2.7.2 NJOY Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 NJOY SWOT Analysis
2.7.4 NJOY Product and Services
2.7.5 NJOY Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.8 McNeil AB
2.8.1 McNeil AB Details
2.8.2 McNeil AB Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 McNeil AB SWOT Analysis
2.8.4 McNeil AB Product and Services
2.8.5 McNeil AB Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.9 Takeda pharmaceutical
2.9.1 Takeda pharmaceutical Details
2.9.2 Takeda pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Takeda pharmaceutical SWOT Analysis
2.9.4 Takeda pharmaceutical Product and Services
2.9.5 Takeda pharmaceutical Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.10 Elder Pharma
2.10.1 Elder Pharma Details
2.10.2 Elder Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Elder Pharma SWOT Analysis
2.10.4 Elder Pharma Product and Services
2.10.5 Elder Pharma Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.11 VMR products
2.11.1 VMR products Details
2.11.2 VMR products Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 VMR products SWOT Analysis
2.11.4 VMR products Product and Services
2.11.5 VMR products Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.12 Lorillard
2.12.1 Lorillard Details
2.12.2 Lorillard Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Lorillard SWOT Analysis
2.12.4 Lorillard Product and Services
2.12.5 Lorillard Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
2.13 VaporCorp
2.13.1 VaporCorp Details
2.13.2 VaporCorp Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 VaporCorp SWOT Analysis
2.13.4 VaporCorp Product and Services
2.13.5 VaporCorp Anti-Smoking Products Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anti-Smoking Products Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-Smoking Products Players Market Share
3.2.2 Top 10 Anti-Smoking Products Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anti-Smoking Products Revenue and Market Share by Regions
4.2 North America Anti-Smoking Products Revenue and Growth Rate (2015-2020)
4.3 Europe Anti-Smoking Products Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Smoking Products Revenue and Growth Rate (2015-2020)
4.5 South America Anti-Smoking Products Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anti-Smoking Products Revenue and Growth Rate (2015-2020)
5 North America Anti-Smoking Products Revenue by Countries
5.1 North America Anti-Smoking Products Revenue by Countries (2015-2020)
5.2 USA Anti-Smoking Products Revenue and Growth Rate (2015-2020)
5.3 Canada Anti-Smoking Products Revenue and Growth Rate (2015-2020)
5.4 Mexico Anti-Smoking Products Revenue and Growth Rate (2015-2020)
6 Europe Anti-Smoking Products Revenue by Countries
6.1 Europe Anti-Smoking Products Revenue by Countries (2015-2020)
6.2 Germany Anti-Smoking Products Revenue and Growth Rate (2015-2020)
6.3 UK Anti-Smoking Products Revenue and Growth Rate (2015-2020)
6.4 France Anti-Smoking Products Revenue and Growth Rate (2015-2020)
6.5 Russia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
6.6 Italy Anti-Smoking Products Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anti-Smoking Products Revenue by Countries
7.1 Asia-Pacific Anti-Smoking Products Revenue by Countries (2015-2020)
7.2 China Anti-Smoking Products Revenue and Growth Rate (2015-2020)
7.3 Japan Anti-Smoking Products Revenue and Growth Rate (2015-2020)
7.4 Korea Anti-Smoking Products Revenue and Growth Rate (2015-2020)
7.5 India Anti-Smoking Products Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
8 South America Anti-Smoking Products Revenue by Countries
8.1 South America Anti-Smoking Products Revenue by Countries (2015-2020)
8.2 Brazil Anti-Smoking Products Revenue and Growth Rate (2015-2020)
8.3 Argentina Anti-Smoking Products Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anti-Smoking Products by Countries
9.1 Middle East & Africa Anti-Smoking Products Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
9.3 UAE Anti-Smoking Products Revenue and Growth Rate (2015-2020)
9.4 Egypt Anti-Smoking Products Revenue and Growth Rate (2015-2020)
9.5 South Africa Anti-Smoking Products Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anti-Smoking Products Revenue and Market Share by Type (2015-2020)
10.2 Global Anti-Smoking Products Market Forecast by Type (2019-2024)
10.3 Nicotine Replacement Therapy Revenue Growth Rate (2015-2025)
10.4 Drug therapy Revenue Growth Rate (2015-2025)
10.5 E-cigarettes Revenue Growth Rate (2015-2025)
11 Global Anti-Smoking Products Market Segment by Application
11.1 Global Anti-Smoking Products Revenue Market Share by Application (2015-2020)
11.2 Anti-Smoking Products Market Forecast by Application (2019-2024)
11.3 Smokers aged 18–24 Revenue Growth (2015-2020)
11.4 Smokers aged 25–44 Revenue Growth (2015-2020)
11.5 Smokers aged 45–64 Revenue Growth (2015-2020)
11.6 Smokers aged 65 years or older Revenue Growth (2015-2020)
12 Global Anti-Smoking Products Market Size Forecast (2021-2025)
12.1 Global Anti-Smoking Products Market Size Forecast (2021-2025)
12.2 Global Anti-Smoking Products Market Forecast by Regions (2021-2025)
12.3 North America Anti-Smoking Products Revenue Market Forecast (2021-2025)
12.4 Europe Anti-Smoking Products Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anti-Smoking Products Revenue Market Forecast (2021-2025)
12.6 South America Anti-Smoking Products Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anti-Smoking Products Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anti-Smoking Products Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Smoking Products by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Smoking Products Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anti-Smoking Products Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Anti-Smoking Products Major Business
Table 7. Pfizer Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Anti-Smoking Products Product and Solutions
Table 10. Pfizer Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Imperial Tobacco Corporate Information, Location and Competitors
Table 12. Imperial Tobacco Anti-Smoking Products Major Business
Table 13. Imperial Tobacco Anti-Smoking Products Total Revenue (USD Million) (2018-2019)
Table 14. Imperial Tobacco SWOT Analysis
Table 15. Imperial Tobacco Anti-Smoking Products Product and Solutions
Table 16. Imperial Tobacco Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GSK Corporate Information, Location and Competitors
Table 18. GSK Anti-Smoking Products Major Business
Table 19. GSK Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 20. GSK SWOT Analysis
Table 21. GSK Anti-Smoking Products Product and Solutions
Table 22. GSK Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Cipla Corporate Information, Location and Competitors
Table 24. Cipla Anti-Smoking Products Major Business
Table 25. Cipla Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 26. Cipla SWOT Analysis
Table 27. Cipla Anti-Smoking Products Product and Solutions
Table 28. Cipla Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Revolymer plc Corporate Information, Location and Competitors
Table 30. Revolymer plc Anti-Smoking Products Major Business
Table 31. Revolymer plc Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 32. Revolymer plc SWOT Analysis
Table 33. Revolymer plc Anti-Smoking Products Product and Solutions
Table 34. Revolymer plc Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis International Corporate Information, Location and Competitors
Table 36. Novartis International Anti-Smoking Products Major Business
Table 37. Novartis International Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 38. Novartis International SWOT Analysis
Table 39. Novartis International Anti-Smoking Products Product and Solutions
Table 40. Novartis International Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. NJOY Corporate Information, Location and Competitors
Table 42. NJOY Anti-Smoking Products Major Business
Table 43. NJOY Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 44. NJOY SWOT Analysis
Table 45. NJOY Anti-Smoking Products Product and Solutions
Table 46. NJOY Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. McNeil AB Corporate Information, Location and Competitors
Table 48. McNeil AB Anti-Smoking Products Major Business
Table 49. McNeil AB Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 50. McNeil AB SWOT Analysis
Table 51. McNeil AB Anti-Smoking Products Product and Solutions
Table 52. McNeil AB Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Takeda pharmaceutical Corporate Information, Location and Competitors
Table 54. Takeda pharmaceutical Anti-Smoking Products Major Business
Table 55. Takeda pharmaceutical Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 56. Takeda pharmaceutical SWOT Analysis
Table 57. Takeda pharmaceutical Anti-Smoking Products Product and Solutions
Table 58. Takeda pharmaceutical Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Elder Pharma Corporate Information, Location and Competitors
Table 60. Elder Pharma Anti-Smoking Products Major Business
Table 61. Elder Pharma Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 62. Elder Pharma SWOT Analysis
Table 63. Elder Pharma Anti-Smoking Products Product and Solutions
Table 64. Elder Pharma Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. VMR products Corporate Information, Location and Competitors
Table 66. VMR products Anti-Smoking Products Major Business
Table 67. VMR products Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 68. VMR products SWOT Analysis
Table 69. VMR products Anti-Smoking Products Product and Solutions
Table 70. VMR products Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Lorillard Corporate Information, Location and Competitors
Table 72. Lorillard Anti-Smoking Products Major Business
Table 73. Lorillard Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 74. Lorillard SWOT Analysis
Table 75. Lorillard Anti-Smoking Products Product and Solutions
Table 76. Lorillard Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. VaporCorp Corporate Information, Location and Competitors
Table 78. VaporCorp Anti-Smoking Products Major Business
Table 79. VaporCorp Anti-Smoking Products Total Revenue (USD Million) (2017-2018)
Table 80. VaporCorp SWOT Analysis
Table 81. VaporCorp Anti-Smoking Products Product and Solutions
Table 82. VaporCorp Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Anti-Smoking Products Revenue (Million USD) by Players (2015-2020)
Table 84. Global Anti-Smoking Products Revenue Share by Players (2015-2020)
Table 85. Global Anti-Smoking Products Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Anti-Smoking Products Revenue Market Share by Regions (2015-2020)
Table 87. North America Anti-Smoking Products Revenue by Countries (2015-2020)
Table 88. North America Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Table 89. Europe Anti-Smoking Products Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Anti-Smoking Products Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Anti-Smoking Products Revenue by Countries (2015-2020)
Table 92. South America Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Anti-Smoking Products Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Table 95. Global Anti-Smoking Products Revenue (Million USD) by Type (2015-2020)
Table 96. Global Anti-Smoking Products Revenue Share by Type (2015-2020)
Table 97. Global Anti-Smoking Products Revenue Forecast by Type (2021-2025)
Table 98. Global Anti-Smoking Products Revenue by Application (2015-2020)
Table 99. Global Anti-Smoking Products Revenue Share by Application (2015-2020)
Table 100. Global Anti-Smoking Products Revenue Forecast by Application (2021-2025)
Table 101. Global Anti-Smoking Products Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anti-Smoking Products Picture
Figure 2. Global Anti-Smoking Products Revenue Market Share by Type in 2019
Figure 3. Nicotine Replacement Therapy Picture
Figure 4. Drug therapy Picture
Figure 5. E-cigarettes Picture
Figure 6. Anti-Smoking Products Revenue Market Share by Application in 2019
Figure 7. Smokers aged 18–24 Picture
Figure 8. Smokers aged 25–44 Picture
Figure 9. Smokers aged 45–64 Picture
Figure 10. Smokers aged 65 years or older Picture
Figure 11. Global Anti-Smoking Products Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Anti-Smoking Products Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Anti-Smoking Products Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Anti-Smoking Products Revenue Market Share in 2019
Figure 20. Global Top 10 Players Anti-Smoking Products Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Anti-Smoking Products Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Anti-Smoking Products Revenue Market Share by Regions (2015-2020)
Figure 24. Global Anti-Smoking Products Revenue Market Share by Regions in 2018
Figure 25. North America Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 26. Europe Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 28. South America Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 30. North America Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Figure 31. North America Anti-Smoking Products Revenue Market Share by Countries in 2019
Figure 32. USA Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 33. Canada Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 35. Europe Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Anti-Smoking Products Revenue Market Share by Countries in 2019
Figure 37. Germany Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 38. UK Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 39. France Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 40. Russia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 41. Italy Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Anti-Smoking Products Revenue Market Share by Countries in 2019
Figure 44. China Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 45. Japan Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 46. Korea Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 47. India Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 49. South America Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Figure 50. South America Anti-Smoking Products Revenue Market Share by Countries in 2019
Figure 51. Brazil Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Anti-Smoking Products Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Anti-Smoking Products Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 56. UAE Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Anti-Smoking Products Revenue and Growth Rate (2015-2020)
Figure 59. Global Anti-Smoking Products Revenue Share by Type (2015-2020)
Figure 60. Global Anti-Smoking Products Revenue Share by Type in 2019
Figure 61. Global Anti-Smoking Products Market Share Forecast by Type (2021-2025)
Figure 62. Global Nicotine Replacement Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Drug therapy Revenue Growth Rate (2015-2020)
Figure 64. Global E-cigarettes Revenue Growth Rate (2015-2020)
Figure 65. Global Anti-Smoking Products Revenue Share by Application (2015-2020)
Figure 66. Global Anti-Smoking Products Revenue Share by Application in 2019
Figure 67. Global Anti-Smoking Products Market Share Forecast by Application (2021-2025)
Figure 68. Global Smokers aged 18–24 Revenue Growth Rate (2015-2020)
Figure 69. Global Smokers aged 25–44 Revenue Growth Rate (2015-2020)
Figure 70. Global Smokers aged 45–64 Revenue Growth Rate (2015-2020)
Figure 71. Global Smokers aged 65 years or older Revenue Growth Rate (2015-2020)
Figure 72. Global Anti-Smoking Products Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Anti-Smoking Products Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Anti-Smoking Products Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Anti-Smoking Products Revenue Market Forecast (2021-2025)
Figure 76. Europe Anti-Smoking Products Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Anti-Smoking Products Revenue Market Forecast (2021-2025)
Figure 78. South America Anti-Smoking Products Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Anti-Smoking Products Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
禁煙の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Smoking Cessation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 耐衝撃ズボンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Anti-shock Trousers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 耐衝撃ゴーグルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-shock Goggle market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-shock Goggle market re…
- 防曇スイミングゴーグルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Fog Swimming Goggles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Fog Swimming G…
- 抗破傷風免疫グロブリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-tetanus Immunoglobulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-tetanus Immu…